I personally think it was a big mistake not to buy

New Post Public Reply Private Reply Replies (3) Message Board
aidenb reallypeople? #46623
937
I personally think it was a big mistake not to buy IncellDx. Dr. Patterson is a good scientist and good at developing new products(kits). He would have made us billions of dollars for hist tests. (paid for the BO itself)

Now, Bruce has used CytoDyn data to understand the issue and create kits, and once Bruce's kit are approved, as opposed to selling them, they have get a mediator or go for a trial on why the he built a kit with the data, for which he was paid for his consultation.

At the end we are going to own some of his sales, but at a costs of months or year of mediation or fight.

Even now, it is easier to buy his company, and work out for a number of years, for a cost, and sure he can make us get to the market faster, get new indications, and supplementary kits.

Again, I'm not the BOD of CytoDyn, but I hope someone read this, and think it might be a win-win for both corps.

Quote:
Interesting poster on SA


OU2G
Comments188 | + Follow
Dr. Patterson nails it again and has put fear into those shorting this company. I have no doubt the share price will be going up on Monday because he infused confidence into the blackhole of certainty Nader creates.
It is time CYDY admit that Bruce is a ringer for representing the Covid 19 indications for Leronlimab. Bruce CREATED the science and IS the best most credible spokesperson for CYDY on CV19 and Cancer - period. Dr. Jay is nice, Dr. Yang is helpful however Dr. Patterson is the most important to shareholders... not just for PR.
Ask yourself, where would the share price be if Bruce was welcomed to collaborate with CYDY vs. being pushed away by Nader and Kelly. Could we have held around $8, 20% off the high pre June 30th short attack during these volatile OTC days?
Why didn’t CYDY strike a revenue sharing deal with Bruce? Based on what I heard last night, Incelldx’s test kits are going to make a killing and CYDY investors will be forced to watch from the sidelines or does Nader and Co. have something more obtuse in mind? Like, challenge his patent... whoa.
Which choice will Nader and Co. make?
1) Ignore Bruce and give up diagnostics revenue
2) Challenge patent and directly compete
3) Partner
4) Merge/acquire
Isn’t it funny how junior executives can’t see two moves ahead? I would like them to explain to investors why they don’t see diagnostics for this platform drug as important if they chose option 1, the apparent course we are on.
If they make choice 2 and challenge his patent, I’m definitely selling. Bruce mentioned several “other MABs that are very exciting” so that means we could lose Bruce to the next smart pharmaceutical that would treat him right. I invested in Bruce, and many of you did too, so if that is the plan, we all have to consider the implications.
Regardless, it is clear, Bruce will gladly switch teams if he finds a drug that is better for humanity and that is a complement to Bruce and a direct result of Nader and Co. Not choosing options 3 or 4.
Furthermore, remember that comment Nader said about “we don’t need research” well, that is another astonishing statement made by our illustrious CEO that illustrates the shortsightedness of this executive team.
I wonder if the increased market cap that Bruce might bring be worth avoiding the “lose or lose more” scenarios presented in options 1 and 2 that Nader and Co seem hellbent to make.
I do.
Let’s hope Nader’s stubborn leadership style doesn’t end in the mantra
“Fire Nader. Save CytoDyn.”
From one former CEO to another - stop self-inflicting injury.
OU (edited)

Read More: https://investorshangout.com/post/newpost/605...z6TvED9mnQ
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HNTB Expands in Capital Region: A Strategic Move

Updated Category News Views 2

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Continue Reading
Lavior and CR Fitness Team for Wellness Reach

Updated Category News Views 2

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Continue Reading
Annex Brands Grows with Bastrop's PostalAnnex Opening

Updated Category News Views 4

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Continue Reading
Lititz Mutual Embraces AI with Guidewire ProNavigator

Updated Category News Views 6

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

Continue Reading
NACD Honors Top Board Leaders with 2026 Awards

Updated Category News Views 12

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Continue Reading
Anixa Expands Global Footprint with Aussie Patent

Updated Category News Views 5

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...

Continue Reading
Lawsuit Targets Electrical Consultants' Labor Practices

Updated Category News Views 4

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

Continue Reading
Tenera Care's Tech Triumph: Halving Falls with Simplicity

Updated Category News Views 6

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Continue Reading
U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

Updated Category News Views 5

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

Continue Reading
Molex's VersaBeam Mini Pushes AI Data Center Limits

Updated Category News Views 3

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Continue Reading

Top 5 Most Recently Viewed Articles

VistaJet Expands Domestic Flight Operations in Saudi Arabia

Updated Category News Views 132

VistaJet's Breakthrough in Domestic Aviation VistaJet, recognized as a global leader in private aviation, proudly announces its pioneering role as the first foreign operator to provide domestic flight services within Saudi Arabia. This groundbreaking endeavor aligns with the Kingdom's strategic goals and solidifies VistaJet's commitment to fostering efficient aviation...

Continue Reading
Cycurion, Inc. Revealing Q2 2025 Results and Strategic Moves

Updated Category News Views 106

Cycurion, Inc. Plans to Announce Q2 2025 Financial Results Cycurion, Inc. (NASDAQ: CYCU), known for its expertise in cybersecurity and IT solutions, is gearing up to present its financial results for the second quarter of 2025. This leading provider has a dynamic approach to enhancing its market position through various strategic initiatives. Highlights of Recent...

Continue Reading
PicS Faces Securities Fraud Class Action: What's Next?

Updated Category News Views 4

PicS' Troubled Waters: A Securities Fraud Whirlwind Folks, we've got a real quagmire brewing with PicS N.V. (NASDAQ: PICS). If you snagged a piece of this company's Class A common stock during their IPO back in January, you might find yourself neck-deep in legal mumbo jumbo soon enough. August 4, 2026, is the date etched in stone for any investors wanting a say in this...

Continue Reading
Exploring Workday's Market Sentiment and Stock Trends

Updated Category News Views 139

Understanding Workday's Market Dynamics Workday Inc (NYSE: WDAY) has seen a notable increase in its short percent of float, which has risen by 6.06% according to the latest reports. Currently, the company has approximately 8.30 million shares sold short, representing about 3.85% of all regular shares available for trading. This indicates a rising trend in short selling...

Continue Reading
IDV Expands Truck Supply to Support Italian Army's Fleet Growth

Updated Category News Views 140

IDV Expands Supply of Tactical Trucks to the Italian Army IDV, a renowned brand of the Iveco Group, is pleased to announce a significant expansion of its contract with the Italian Army, aiming to supply an additional 658 tactical-logistic trucks. This new addition enhances the existing commitment that dates back to a contract signed in 2024 for 1,453 vehicles. Modernizing...

Continue Reading